ANN ARBOR, Mich., June 8, 2016 /PRNewswire/ -- Hygieia, a digital insulin enhancement company dedicated to making insulin therapy easier for everyone involved, announced today that John L. Brooks III has joined the company's Board of Directors.
"John is a recognized leader in the diabetes space and brings a wealth of operational and management experience to our board," said Eran Bashan, Hygieia CEO. "His strategic, financial and funding expertise will be invaluable to Hygieia as we work to grow our company and transform insulin management to achieve better outcomes for patients and clinicians, and reduce the cost of care."
Hygieia has created the d-Nav® insulin guidance service, which combines smart cloud-based technology and a small team of healthcare professionals to provide valuable support to primary care physicians and people with diabetes. The d-Nav service provides personalized adjustments to enhance and simplify insulin dosing, maximizing its effectiveness for patients and the physicians who prescribe it. In the United States, Blue Cross Blue Shield of Michigan is currently evaluating d-Nav in a one year, 1,000-patient demonstration project.
Mr. Brooks currently serves as president and chief executive officer of Arete Worldwide, LLC, a consulting firm that provides services to a global network of partners and academic experts working together to drive disruptive solutions that address the obesity, pre-diabetes, and diabetes pandemics. He also is a managing director at Healthcare Capital, LLC. Previously, Mr. Brooks held multiple leadership positions at the Joslin Diabetes Center in Boston, serving as president and chief executive officer from 2011 to 2015, and chairman and finance committee chair from 2005 to 2011. From 2009 to 2014, Brooks was also the chief executive officer and chairman of Reflectance Medical, Inc., a non-invasive metabolic parameters sensor company that was acquired by Sotera Wireless. Prior to assuming these positions, Mr. Brooks founded Prism Venture Partners, overseeing fundraising, investment and capital deployment and co-founded Insulet Corporation, an innovative insulin pump company.
"I've been immersed in diabetes and disruptive technologies for many years, and the d-Nav service is one of the most rational, integrated and potentially effective solutions I've seen," said Brooks. "I look forward to working with the Hygieia board and management team because I believe this comprehensive, connected-health solution has great potential to benefit everyone involved with and impacted by insulin therapy."
Hygieia is a digital insulin enhancement company dedicated to making insulin therapy easier for everyone involved. The company is based in Ann Arbor, Mich. and has a wholly owned subsidiary in Northern Ireland. More information is available at www.hygieia.com
Forward Health Communications, Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/hygieia-appoints-john-l-brooks-iii-to-its-board-of-directors-300281463.html